Skip to main content

Cryder Capital Partners LLP

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1633969 London, X0

Position in TMO

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$210,160,586
+$25,010,575 QoQ
Shares Held
419,181
+11.3% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
13.24%
of 13F equity value
Holder Rank
#115
of 2,606 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Cryder Capital Partners LLP holds $210,160,586 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page
419,181 $210,160,586

All Filings in TMO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $210,160,586 419,181
2026-03-31 $185,150,011 376,681
2025-12-31 $218,267,805 376,681
2025-09-30 $167,174,753 344,676
2025-06-30 $139,752,330 344,676
2025-03-31 $161,620,977 324,801
2024-12-31 $168,971,224 324,801
2024-09-30 $179,603,655 290,353
2024-06-30 $160,565,209 290,353
2024-03-31 $245,655,381 422,662
2023-12-31 $214,637,144 404,373
2023-09-30 $198,464,195 392,090
2023-06-30 $205,255,406 393,398
2023-03-31 $227,482,287 394,681
2022-12-31 $217,346,879 394,681
2022-09-30 $219,373,876 432,528
2022-06-30 $235,199,494 432,925
2022-03-31 $237,628,536 402,317
2021-12-31 $258,112,452 386,836
2021-09-30 $221,011,011 386,836
2021-06-30 $193,353,766 383,281
2021-03-31 $136,269,135 298,587
2020-12-31 $136,095,792 292,189
2020-09-30 $156,438,924 354,319
2020-06-30 $128,383,946 354,319
2020-03-31 $100,484,868 354,319